O'Shaughnessy Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $45.9M | Buy |
797,026
+196,747
| +33% | +$11.3M | 0.21% | 93 |
|
|
2026
Q1 | $36.4M | Buy |
600,279
+81,506
| +16% | +$4.75M | 0.18% | 119 |
|
|
2025
Q4 | $28M | Buy |
518,773
+266,384
| +106% | +$12.8M | 0.15% | 141 |
|
|
2025
Q3 | $11.4M | Buy |
252,389
+11,808
| +5% | +$551K | 0.07% | 306 |
|
|
2025
Q2 | $11.1M | Sell |
240,581
-278,539
| -54% | -$13.7M | 0.08% | 278 |
|
|
2025
Q1 | $31.7M | Sell |
519,120
-94,258
| -15% | -$5.49M | 0.25% | 84 |
|
|
2024
Q4 | $34.7M | Buy |
613,378
+61,998
| +11% | +$3.46M | 0.29% | 72 |
|
|
2024
Q3 | $29M | Buy |
551,380
+69,154
| +14% | +$3.24M | 0.26% | 77 |
|
|
2024
Q2 | $20M | Buy |
482,226
+97,787
| +25% | +$4.38M | 0.21% | 110 |
|
|
2024
Q1 | $20.8M | Buy |
384,439
+176,238
| +85% | +$8.98M | 0.23% | 93 |
|
|
2023
Q4 | $10.7M | Buy |
208,201
+96,329
| +86% | +$5.06M | 0.14% | 165 |
|
|
2023
Q3 | $6.49M | Buy |
111,872
+15,569
| +16% | +$954K | 0.1% | 235 |
|
|
2023
Q2 | $6.16M | Sell |
96,303
-18,315
| -16% | -$1.23M | 0.09% | 236 |
|
|
2023
Q1 | $7.94M | Sell |
114,618
-106,082
| -48% | -$7.48M | 0.12% | 185 |
|
|
2022
Q4 | $15.9M | Buy |
220,700
+23,640
| +12% | +$1.78M | 0.26% | 112 |
|
|
2022
Q3 | $14M | Sell |
197,060
-147,130
| -43% | -$10.7M | 0.26% | 108 |
|
|
2022
Q2 | $26.5M | Buy |
344,190
+5,864
| +2% | +$447K | 0.49% | 52 |
|
|
2022
Q1 | $24.7M | Buy |
338,326
+63,037
| +23% | +$4.23M | 0.41% | 64 |
|
|
2021
Q4 | $17.2M | Sell |
275,289
-5,341
| -2% | -$313K | 0.3% | 97 |
|
|
2021
Q3 | $16.6M | Buy |
280,630
+35,851
| +15% | +$2.36M | 0.34% | 82 |
|
|
2021
Q2 | $16.4M | Buy |
244,779
+217,217
| +788% | +$14.2M | 0.33% | 90 |
|
|
2021
Q1 | $1.74M | Sell |
27,562
-22,503
| -45% | -$1.4M | 0.04% | 284 |
|
|
2020
Q4 | $3.11M | Sell |
50,065
-176
| -0.4% | -$10.8K | 0.08% | 157 |
|
|
2020
Q3 | $3.03M | Sell |
50,241
-1,614
| -3% | -$97.1K | 0.09% | 137 |
|
|
2020
Q2 | $3.05M | Buy |
51,855
+3,483
| +7% | +$208K | 0.09% | 125 |
|
|
2020
Q1 | $2.7M | Buy |
48,372
+40,632
| +525% | +$2.48M | 0.09% | 122 |
|
|
2019
Q4 | $497K | Buy |
7,740
+7,730
| +77,300% | +$443K | 0.01% | 399 |
|
|
2019
Q3 | $1K | Buy |
10
+7
| +233% | +$329 | ﹤0.01% | 891 |
|
|
2019
Q2 | $0 | Buy |
+3
| New | +$140 | ﹤0.01% | 986 |
|
|
2015
Q2 | – | Sell |
-50
| Closed | -$3K | – | 978 |
|
|
2015
Q1 | $3K | Sell |
50
-939
| -95% | -$58.8K | ﹤0.01% | 871 |
|
|
2014
Q4 | $58K | Sell |
989
-6,557
| -87% | -$370K | ﹤0.01% | 639 |
|
|
2014
Q3 | $386K | Sell |
7,546
-9,288
| -55% | -$464K | 0.01% | 435 |
|
|
2014
Q2 | $817K | Sell |
16,834
-441
| -3% | -$21.7K | 0.02% | 360 |
|
|
2014
Q1 | $897K | Buy |
17,275
+2,658
| +18% | +$141K | 0.02% | 338 |
|
|
2013
Q4 | $777K | Buy |
14,617
+14,241
| +3,788% | +$725K | 0.02% | 363 |
|
|
2013
Q3 | $17K | Sell |
376
-83,519
| -100% | -$3.67M | ﹤0.01% | 686 |
|
|
2013
Q2 | $3.75M | Buy |
+83,895
| New | +$3.64M | 0.1% | 160 |
|
Other funds holding BMY
O'Shaughnessy Asset Management's BMY Position: Q2 2026 in Review
O'Shaughnessy Asset Management increased its Bristol-Myers Squibb (BMY) stake by 33% in Q2 2026, buying an estimated $11.3M and bringing the position to 797,026 shares worth $45.9M. The position accounts for 0.21% of the portfolio, ranked #93.
O'Shaughnessy Asset Management first reported a position in BMY in Q2 2013 and has held it in 37 quarters since. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- O'Shaughnessy Asset Management held 797,026 shares of Bristol-Myers Squibb worth $45.9M as of Q2 2026.
- O'Shaughnessy Asset Management bought 196,747 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.3M.
- Bristol-Myers Squibb made up 0.21% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #93 holding.
- O'Shaughnessy Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 37 quarters since.
- 2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.